share_log

开拓药业-B(09939.HK)拟3月26日举行董事会会议审批年度业绩

KINTOR PHARMA-B (09939.HK) intends to hold a Board of Directors meeting on March 26 to approve the annual performance.

Gelonghui Finance ·  Mar 11 08:36

Gelonghui reported on March 11 that KINTOR PHARMA-B (09939.HK) announced that the Board of Directors meeting will be held on March 26, 2025 (Wednesday), to consider and approve the annual performance of the company and its subsidiaries for the year ending December 31, 2024, and its release.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
1
Comment Comment · Views 414

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.